Related Experiment Videos
Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole
Antimicrobial Agents and Chemotherapy
|June 1, 1978
Abstract:
A total of 100 and 97% of Haemophilus influenzae type b strains from major infections were susceptible, respectively, to levels of rifampin and sulfisoxazole attainable in saliva. It is theoretically feasible to eliminate Haemophilus influenzae from the nasopharynx with these drugs.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neutron imaging of the deuterium-tritium tamping gas volume in an inertial confinement fusion hohlraum.
The Review of scientific instruments·2024
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
Journal of internal medicine·2020
Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
Journal of internal medicine·2020
Decreased tibial nerve movement in patients with failed back surgery syndrome and persistent leg pain.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2019
The 2014 Survey on Living with Chronic Diseases in Canada on Mood and Anxiety Disorders: a methodological overview.
Health promotion and chronic disease prevention in Canada : research, policy and practice·2016
Fortuitous detection of campylobacter bacteremia.
Saudi medical journal·2016
In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infections.
Antimicrobial agents and chemotherapy·2026
Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coli.
Antimicrobial agents and chemotherapy·2026
A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection model.
Antimicrobial agents and chemotherapy·2026
Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinations.
Antimicrobial agents and chemotherapy·2026
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones dissemination.
Antimicrobial agents and chemotherapy·2026
Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis-derived fungal metabolite targeting pyruvate kinase II.
Antimicrobial agents and chemotherapy·2026
L5 Corpectomy in a 12-Year-Old Owing to Rosai-Dorfman Disease: A Case Report.
International journal of spine surgery·2026
Compromised nasal skin in functional rhinoplasty: a literature review and proposal of a clinical management protocol.
Acta otorrinolaringologica espanola·2026